Clinical trial
Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial
NCT02049307 is registered in ClinicalTrials.gov with Hennepin Healthcare Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial
- Lead sponsor
- Hennepin Healthcare Research Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 16, 2014
- Completion date
- December 14, 2018
- Enrollment
- 108 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.